Ireland· IE-PA-PA0690/015/001
TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation
A 99mtc-technetium-pentetat product containing pentetic acid, registered in Ireland by Curium Netherlands B.V.. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium-pentetat is registered in 8 of 19 countries.
Countries holding a registration under ATC V09CA01 (99mtc-technetium-pentetat), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
99mtc-technetium-pentetat · ATC V09CA01
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- PENTETIC ACID
- Manufacturer
- Curium Netherlands B.V.
- Country
- Ireland (IE)
- ATC code
- V09CA01
- ATC class
- 99mTc-Technetium-Pentetat
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0690/015/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
99mtc-technetium-pentetat in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDRAXIMAGE DTPAJubilant DraxImage Inc., dba Jubilant Radiopharma
- FranceCa-DTPA 250 mg/mL, solution injectablePHARMACIE CENTRALE DES ARMEES- PCA
- CzechiaTECHNESCAN DTPACurium Netherlands B.V., Petten
- GermanyTechnescan DtpaCurium Netherlands B.V.
- CanadaDRAXIMAGE DTPAJUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
- United KingdomTechnescan DTPA kit for radiopharmaceutical preparationCurium Pharma UK Ltd
- NetherlandsTechnescan DTPA 20,8 mg, kit voor radiofarmaceutisch preparaatCurium Netherlands B.V.
- SwedenTechneScan DTPA 20,8 mg Beredningssats för radioaktivt läkemedelCurium Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Technescan Dtpa
- Belgium · Technescan Dtpa
- Czechia · Technescan Dtpa
- Germany · Technescan Dtpa
- Denmark · Technescan Dtpa
- Spain · Dtpa Technescan
- Finland · Technescan Dtpa
- France · Technescan Dtpa
- United Kingdom (Northern Ireland) · Technescan Dtpa
- Greece · Technescan Dtpa
- Hungary · Dtpa Izotóp Intézet, Renon
- Italy · Technescan Dtpa
- Netherlands · Technescan Dtpa
- Portugal · Technescan Dtpa
- Sweden · Technescan Dtpa
- Slovakia · Technescan Dtpa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1951a4d9-67a4-4db9-8b81-bd6669971cfc GET /v1/drugs/1951a4d9-67a4-4db9-8b81-bd6669971cfc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kit for radiopharmaceutical preparation",
"routes": [
"Inhalation use",
"Intravenous use",
"Oral use"
],
"source": "hpra",
"atc_all": [
"V09CA01",
"V09EA01"
],
"strength": null,
"pa_number": "PA0690/015/001",
"substances": [
"PENTETIC ACID"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "22/01/1999",
"dispensing_status": "Product subject to Restricted Prescription (C)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about 99mtc-technetium-pentetat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.